MULTI-001 Nivolumab v7
MULTI-002 Carboplatin and etoposide v1
MULTI-014 Irinotecan & Capecitabine v1
MULTI-018 Larotrectinib v1
MULTI-019 Entrectinib v1
UGI-037 DCF v3
UGI-039 Modified Folfirinox (palliative) v5
UGI-040 Everolimus NET v4
UGI-045 Capecitabine & Oxaliplatin v3
UGI-047 Nab-Paclitaxel (Abranxane) and Gemcitabine v5 UGI-048 Regorafenib v3
UGI-058 FLOT v1
UGI-059 Capecitabine for resected biliary tract cancer v1
UGI-060 Lenvatinib (LENVIMA®) v1
UGI-061 Folfirinox (adjuvant) v1
UGI-065 Nivolumab for metastatic oesophageal cancer (EAMs) v1
UGI-066 Atezolizumab and Bevacizumab v2
UGI-067 Pemigatinib v2
